Table 2.
Fold change of the percentage of growth inhibition of the NSCLC cell lines following treatment with chemotherapeutic drugs combined with pentoxifylline vs. without pentoxifylline
NSCLC cell lines | Combination treatment consisting of pentoxifylline with | |||
Paclitaxel | Vinorelbine | Carboplatin | Vinorelbine plus carboplatin | |
NCI-H460 | 2.14 | 1.33 | 1.86 | 1.78 |
NCI-H460/R | 1.64 | 2.36 | 1.74 | 2.42 |
A549 | 1.5 | 1.25 | 1.41 | 1.62 |
A549-CDR2 | 1.23 | 1.53 | 1.19 | 1.43 |
NSCLC: Non-small cell lung cancer.